London · Delayed Price · Currency is GBP · Price in GBX Prudential Earnings Call Transcripts
Fiscal Year 2025
-
Achieved double-digit growth in new business profit, operating profit, and dividends in 2025, with strong performance in China and Hong Kong and robust capital returns planned through 2027. Agency transformation and bancassurance expansion remain key growth drivers.
-
Delivered double-digit growth in all key metrics for 2025, with broad-based performance across markets and channels, and strong capital returns to shareholders. Guidance for 2026 remains double-digit growth, with over $7 billion to be returned to shareholders by 2027.
-
Double-digit growth achieved across key metrics in H1 2025, with strong capital generation and enhanced shareholder returns planned. Agency and bancassurance channels both contributed, with targeted investments driving operational improvements and confidence in meeting 2027 objectives.
-
Double-digit growth in new business profit, operating earnings, and free surplus marked a strong H1 2025, with robust performance across core Asian and African markets. Enhanced capital returns and a $5B+ shareholder return program are on track, supported by disciplined execution.
Fiscal Year 2024
-
New business profit rose 11% to $3.1B, with adjusted operating profit per share up 8%. 2025 guidance targets over 10% growth in key metrics, and a $2B buyback is accelerated. Strategic focus includes agency expansion, digital investments, and a new India health JV.
-
New business profit rose 8% to $1.5B in H1 2024, with strong operating profit and margin improvements. Growth was broad-based across markets and channels, supported by digital and capability investments, and the group remains on track for its 2027 targets.
-
New business profit rose 8% ex-economics to $1.5B, with operating profit up 9% and a $2B buyback launched. Segment growth was broad-based, with strong bancassurance and health, and robust capital and liquidity positions maintained.
-
A $2 billion share buyback over two years was announced, supported by a strong capital base and clarified rating agency treatment. The free surplus ratio will remain above 200% post-buyback, with dividend growth guidance unchanged at 7%-9%. Strategic focus remains on organic growth, selective partnerships, and disciplined capital allocation.